Advertisement
Table 3 Subgroup analysis of medical expenditures for esophageal cancer diagnosis and treatment per patient
| Variable | Expenditure per patient during 2002–2011 (CNY) | Statisticsa | P | Expenditure per patient during 2009–2011 (CNY) | Statisticsa | P |
|---|---|---|---|---|---|---|
| Overall | 38,666 (38,178–39,155) | 45,319 (44,425–46,213) | ||||
| Region | 649.44 | <0.001 | 306.1 | <0.001 | ||
| Eastern | 41,943 (41,202–42,684) | 47,213 (46,021–48,406) | ||||
| Central | 40,410 (39,646–41,173) | 52,765 (51,100–54,430) | ||||
| Western | 30,234 (29,200–31,269) | 32,555 (30,585–34,526) | ||||
| Hospital type | −6.75 | <0.001 | −1.20 | 0.228 | ||
| General hospital | 36,684 (35,663–37,704) | 45,706 (43,883–47,529) | ||||
| Specialized hospital | 39,256 (38,700–39,812) | 45,182 (44,157–46,207) | ||||
| Hospital level | 25.60 | <0.001 | 13.26 | <0.001 | ||
| 3A | 40,134 (39,625–40,643) | 46,751 (45,824–47,677) | ||||
| 3A less | 22,052 (20,621–23,483) | 26,409 (23,612–29,206) | ||||
| Number of clinical visits per patient | 889.53 | <0.001 | 204.28 | < 0.001 | ||
| 1 | 29,089 (28,651–29,528) | 34,858 (33,981–35,735) | ||||
| 2 | 46,633 (45,530–47,737) | 53,959 (52,002–55,917) | ||||
| 3 | 59,441 (57,524–61,357) | 60,407 (57,497–63,317) | ||||
| 4+ | 68,928 (66,774–71,082) | 69,055 (65,749–72,360) | ||||
| Gender | 5.64 | <0.001 | 1.84 | 0.066 | ||
| Male | 39,521 (38,961–40,082) | 46,046 (45,017–47,074) | ||||
| Female | 35,585 (34,605–36,564) | 42,768 (40,976–44,561) | ||||
| Age at diagnosis (years) | 8.65 | <0.001 | 14.42 | <0.001 | ||
| <45 | 37,796 (35,539–40,054) | 49,384 (43,380–55,388) | ||||
| 45–54 | 39,237 (38,172–40,302) | 50,732 (48,367–53,096) | ||||
| 55–64 | 39,588 (38,792–40,384) | 46,572 (45,139–48,006) | ||||
| ≥65 | 37,452 (36,647–38,257) | 41,741 (40,426–43,057) | ||||
| Pathologic type | 23.95 | <0.001 | 11.61 | <0.001 | ||
| Squamous cell carcinoma | 40,711 (40,173–41,250) | 48,242 (47,233–49,250) | ||||
| Others | 30,216 (29,032–31,399) | 35,576 (33,636–37,516) | ||||
| Clinical stage | 55.51 | <0.001 | 21.80 | <0.001 | ||
| I | 34,460 (32,902–36,017) | 40,000 (36,878–43,122) | ||||
| II | 39,302 (38,526–40,079) | 47,978 (46,381–49,575) | ||||
| III | 40,353 (39,491–41,214) | 44,962 (43,616–46,309) | ||||
| IV | 37,432 (36,180–38,685) | 42,972 (40,749–45,194) | ||||
| Type of therapy | 758.66 | <0.001 | 270.53 | <0.001 | ||
| Surgery | 38,492 (37,890–39,094) | 47,778 (46,548–49,008) | ||||
| Surgery and chemotherapy | 51,503 (50,316–52,691) | 63,843 (61,535–66,151) | ||||
| Radiotherapy | 27,933 (26,787–29,079) | 29,085 (27,471–30,699) | ||||
| Chemotherapy | 27,805 (26,310–29,299) | 35,671 (33,121–38,222) | ||||
| Radiotherapy and chemotherapy | 53,907 (51,867–55,946) | 57,234 (53,865–60,603) | ||||
| Surgery and radiotherapy | 57,725 (55,041–60,409) | 62,438 (58,708–66,167) | ||||
| Palliative care | 13,846 (12,626–15,067) | 15,627 (13,187–18,067) | ||||
| Others | 23,057 (20,564–25,550) | 21,821 (18,386–25,256) | ||||
